Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameATS 3F AORTIC BIOPROSTHESIS MODEL 1000
Classification Nameheart-valve, non-allograft tissue
ApplicantATS MEDICAL, INC.
PMA NumberP060025
Supplement NumberS003
Date Received01/05/2009
Decision Date03/05/2009
Product Code
LWR[ Registered Establishments with LWR ]
Advisory Committee Cardiovascular
Supplement Typereal-time process
Supplement Reason labeling change - shelf-life
Expedited Review Granted? No
Combination Product Yes
Approval Order Statement 
Approval for extension of the shelf-life of the ats 3f aortic bioprosthesis, model 1000 valves (sizes 19, 21, 23, 25, 27 and 29 mm) from 2 years to 5 years. The device is indicated for ¿. Use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their valve with a prosthetic device. The usual conditions of advanced disease include aortic stenosis, aortic incompetence, and a combination of the two. ¿.
-
-